The methods and conditions for the synthesis of the main metabolite of the selective anxiolytic afobazole, 2-[2-(3-oxomorpholin-4-yl)ethylthio]-5-ethoxybenzimidazole, and its analogs are developed. It is shown that the main metabolite demonstrates an anxiolytic effect in a dose range similar to that of afobazole. It is found that the psychopharmacological profile of the other synthesized compounds (analogs) is characterized by a less pronounced anxiolytic component.
Similar content being viewed by others
References
Jpn. Pat. No. 10978; Chem. Abstr., 58, 13964f (1963).
GB Pat. No. 1,152,814; Chem. Abstr., 72, P12729u (1970).
C. A. Johnson, A. Mohamond, P. Brouant, et al., Med. Chem. Res., 2(4), 247 – 255 (1992).
Jpn. Pat. No. 74 41198; Chem. Abstr., 82, P156308k (1975).
G. G. Naznamov, S. A. Syunyakov, D. V. Chumakov, et al., Psikhiatriya Psikhofarmakoter., No. 4 (8), 8 – 13 (2006).
S. B. Seredenin, A. O. Viglinskaya, T. Ya. Mozhaeva, et al., Eksp. Klin. Farmakol., 71(2), 50 – 52 (2008).
K. M. Lakin and Yu. F. Krylov, Biotransformation of Drugs [in Russian], Meditsina, Moscow (1981), pp. 23 – 24.
RF Pat. Appl. No. 2007137788; Byull. Izobret., No. 12 (2009).
P. Vieles and J. Sequin, Compt. rend., 234, 1980 – 1981 (1952).
R. G. Lister, Psychopharmacol., 92, 180 – 185 (1987).
S. Pellow, P. Chopin, S. Pile, and M. Briley, J. Neurosci. Methods, 14, 149 – 167 (1985).
S. B. Seredenin, T. A. Voronina, G. G. Neznamov, et al., Vestn. Ross. Akad. Med. Nauk, 11, 3 – 9 (1998).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 45, No. 3, pp. 19 – 22, March, 2011.
Rights and permissions
About this article
Cite this article
Mozhaeva, T.Y., Yarkova, M.A., Lezina, V.P. et al. Synthesis and pharmacological activity of the main metabolite of afobazole and its analogs. Pharm Chem J 45, 147–150 (2011). https://doi.org/10.1007/s11094-011-0579-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-011-0579-x